Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Oct 15;89(20):9622–9626. doi: 10.1073/pnas.89.20.9622

Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas.

K H Buetow 1, V C Sheffield 1, M Zhu 1, T Zhou 1, F M Shen 1, O Hino 1, M Smith 1, B J McMahon 1, A P Lanier 1, W T London 1, et al.
PMCID: PMC50184  PMID: 1329103

Abstract

Recent studies of the p53 tumor suppressor locus (designated TP53) in primary hepatocellular carcinoma (PHC) have identified a high frequency of codon 249 mutations. Due to the geographic location from which the samples were obtained and the substitution observed, the mutation was suggested to be attributable to aflatoxin B1 (AFB1) exposure. To determine the generality of this phenomenon, we have examined PHC tissues from 107 geographically and ethnically diverse sources. The frequency of p53 gene mutations was evaluated by using PCR/restriction-digest methods, GC-clamp (G+C-rich sequence) denaturing gradient gel electrophoresis, and DNA sequencing. The mutation rate observed in tumors from high-AFB1-exposure regions (25%) was more than double the rate observed in low-exposure regions (12%) but lower than the 50% frequency previously reported. Codon 249 mutations occurred at a much lower frequency than previously reported (2 of 107 samples examined). These results suggest that changes in DNA encoding p53 may not represent primary oncogenic effects but instead represent genetic changes related to tumor progression. High AFB1 levels may facilitate the generation of these progressional changes, but not by inducing a specific p53 gene mutation at codon 249 as previously reported.

Full text

PDF
9622

Images in this article

9624Image
on p.9624
9625Image
on p.9625
9625Image
on p.9625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts S. R., Lanier A. P., McMahon B. J., Harpster A., Bulkow L. R., Heyward W. L., Murray C. Clustering of hepatocellular carcinoma in Alaska Native families. Genet Epidemiol. 1991;8(2):127–139. doi: 10.1002/gepi.1370080206. [DOI] [PubMed] [Google Scholar]
  2. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  3. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  4. DuBose R. F., Hartl D. L. Rapid purification of PCR products for DNA sequencing using Sepharose CL-6B spin columns. Biotechniques. 1990 Mar;8(3):271–274. [PubMed] [Google Scholar]
  5. Foster P. L., Eisenstadt E., Miller J. H. Base substitution mutations induced by metabolically activated aflatoxin B1. Proc Natl Acad Sci U S A. 1983 May;80(9):2695–2698. doi: 10.1073/pnas.80.9.2695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ganem D., Varmus H. E. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 1987;56:651–693. doi: 10.1146/annurev.bi.56.070187.003251. [DOI] [PubMed] [Google Scholar]
  7. Harris C. C. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells. 1990 May;2(5):146–148. [PubMed] [Google Scholar]
  8. Hayward N. K., Walker G. J., Graham W., Cooksley E. Hepatocellular carcinoma mutation. Nature. 1991 Aug 29;352(6338):764–764. doi: 10.1038/352764a0. [DOI] [PubMed] [Google Scholar]
  9. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  10. Hosono S., Lee C. S., Chou M. J., Yang C. S., Shih C. H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene. 1991 Feb;6(2):237–243. [PubMed] [Google Scholar]
  11. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. doi: 10.1038/350427a0. [DOI] [PubMed] [Google Scholar]
  12. Lamb P., Crawford L. Characterization of the human p53 gene. Mol Cell Biol. 1986 May;6(5):1379–1385. doi: 10.1128/mcb.6.5.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  14. Murray J. C., Demopulos C. M., Lawn R. M., Motulsky A. G. Molecular genetics of human serum albumin: restriction enzyme fragment length polymorphisms and analbuminemia. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5951–5955. doi: 10.1073/pnas.80.19.5951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Myers R. M., Fischer S. G., Lerman L. S., Maniatis T. Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res. 1985 May 10;13(9):3131–3145. doi: 10.1093/nar/13.9.3131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Myers R. M., Lumelsky N., Lerman L. S., Maniatis T. Detection of single base substitutions in total genomic DNA. Nature. 1985 Feb 7;313(6002):495–498. doi: 10.1038/313495a0. [DOI] [PubMed] [Google Scholar]
  17. Myers R. M., Maniatis T., Lerman L. S. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol. 1987;155:501–527. doi: 10.1016/0076-6879(87)55033-9. [DOI] [PubMed] [Google Scholar]
  18. Myers R. M., Maniatis T. Recent advances in the development of methods for detecting single-base substitutions associated with human genetic diseases. Cold Spring Harb Symp Quant Biol. 1986;51(Pt 1):275–284. doi: 10.1101/sqb.1986.051.01.033. [DOI] [PubMed] [Google Scholar]
  19. Newberne P. M., Butler W. H. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res. 1969 Jan;29(1):236–250. [PubMed] [Google Scholar]
  20. Poncz M., Solowiejczyk D., Harpel B., Mory Y., Schwartz E., Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6(1):27–36. doi: 10.3109/03630268208996930. [DOI] [PubMed] [Google Scholar]
  21. Sheffield V. C., Cox D. R., Lerman L. S., Myers R. M. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A. 1989 Jan;86(1):232–236. doi: 10.1073/pnas.86.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  23. Wang Y. B., Lan L. Z., Ye B. F., Xu Y. C., Liu Y. Y., Li W. G. Relation between geographical distribution of liver cancer and climate-aflatoxin B1 in China. Sci Sin B. 1983 Nov;26(11):1166–1175. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES